陳添偉醫生 - 臨床腫瘤科
臨床腫瘤科專科醫生
重點資料
- 醫務委員會註冊已驗證
- 臨床腫瘤科專科醫生香港大學內外全科醫學士 · 香港放射科醫學院院士 · 2007 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
陳添偉醫生是香港註冊的臨床腫瘤科專科醫生。
學歷
保險計劃
常見問題
陳添偉醫生好嗎？
陳添偉醫生是香港註冊的臨床腫瘤科專科醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
陳添偉醫生是做什麼的？
陳添偉醫生是臨床腫瘤科醫生。
研究及論文
共 8 篇
按論文主題篩選
主題由同一批 PubMed 論文的醫學分類整理，不代表醫生提供相關診治服務。
- A territory-wide real-world efficacy and toxicity analysis of abiraterone acetate versus docetaxel in 574 Asian patients with metastatic hormone-sensitive prostate cancer.Clinical genitourinary cancer · 2024
- Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.Frontiers in oncology · 2024
- Prevention of docetaxel-associated febrile neutropenia with primary granulocyte colony-stimulating factor in Chinese metastatic hormone-sensitive and castration-resistant prostate cancer patients.Asia-Pacific journal of clinical oncology · 2021
- Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology.Asia-Pacific journal of clinical oncology · 2021
- Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.Asia-Pacific journal of clinical oncology · 2021
- Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.BJU international · 2019
- Management of advanced prostate cancer in Hong Kong: Insights from an APCCC-Derived survey.Asia-Pacific journal of clinical oncology · 2019
- Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.BJU international · 2018
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明